NLRP12 provides a critical checkpoint for osteoclast differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 33, 2015, Pages 10455-10460

  Krauss, Jennifer L ^a   Zeng, Rong ^a   Hickman Brecks, Cynthia L ^a   Wilson, Justin E ^b   Ting, Jenny P Y ^b   Novack, Deborah V ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative NF B; Bone; NLRP12; Osteoclast

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEOTIDE BINDING LEUCINE RICH REPEAT AND PYRIN DOMAIN CONTAINING RECEPTOR 12; NUCLEOTIDE BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; CYTOKINE; LEUCINE; NFKB1 PROTEIN, MOUSE; NLRP12 PROTEIN, MOUSE; NUCLEOTIDE; SIGNAL PEPTIDE; TNFSF11 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE TURNOVER; CALVARIA; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; RADIATION CHIMERA; ACTIVE TRANSPORT; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; INFLAMMATION; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; OSTEOCLAST;

MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; IMMUNOBLOTTING; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUCINE; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B P50 SUBUNIT; NUCLEOTIDES; OSTEOCLASTS; RANK LIGAND; TUMOR NECROSIS FACTOR-ALPHA; X-RAY MICROTOMOGRAPHY;

EID: 84939817160     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1500196112     Document Type: Article

References (33)

1. Novack DV, Teitelbaum SL (2008) The osteoclast: Friend or foe? Annu Rev Pathol 3:457-484.
2. Vaira S, et al. (2008) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest 118(6):2088-2097.
3. Vaira S, et al. (2008) RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci USA 105(10):3897-3902.
4. Novack DV, et al. (2003) The IkappaB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J Exp Med 198(5):771-781.
5. Razani B, et al. (2010) Negative feedback in noncanonical NF-κB signaling modulates NIK stability through IKKα-mediated phosphorylation. Sci Signal 3(123):ra41.
6. Zarnegar B, Yamazaki S, He JQ, Cheng G (2008) Control of canonical NF-κB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci USA 105(9):3503-3508.
7. Xiao G, Fong A, Sun SC (2004) Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J Biol Chem 279(29):30099-30105.
8. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 18:621-663.
9. Zhong Y, Kinio A, Saleh M (2013) Functions of NOD-like receptors in human diseases. Front Immunol 4:333.
10. Lupfer C, Kanneganti TD (2013) Unsolved mysteries in NLR biology. Front Immunol 4:285.
11. Ye Z, et al. (2008) ATP binding by monarch-1/NLRP12 is critical for its inhibitory function. Mol Cell Biol 28(5):1841-1850.
12. Watari K, et al. (2000) Identification of a melanoma antigen, PRAME, as a BCR/ABLinducible gene. FEBS Lett 466(2-3):367-371.
13. Vladimer GI, et al. (2012) The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 37(1):96-107.
14. Allen IC, et al. (2012) NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36(5): 742-754.
15. Zaki MH, et al. (2011) The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20(5):649-660.
16. Williams KL, et al. (2005) The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor α-, and Mycobacterium tuberculosis-induced proinflammatory signals. J Biol Chem 280(48):39914-39924.
17. Arthur JC, et al. (2010) Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol 185(8):4515-4519.
18. Lich JD, et al. (2007) Monarch-1 suppresses non-canonical NF-κB activation and p52- dependent chemokine expression in monocytes. J Immunol 178(3):1256-1260.
19. Zaki MH, Man SM, Vogel P, Lamkanfi M, Kanneganti TD (2014) Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection. Proc Natl Acad Sci USA 111(1):385-390.
20. Ting JP, Duncan JA, Lei Y (2010) How the noninflammasome NLRs function in the innate immune system. Science 327(5963):286-290.
21. Lich JD, Ting JP (2007) Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions. Microbes Infect 9(5):672-676.
22. Soysa NS, Alles N, Takahashi M, Aoki K, Ohya K (2011) Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide. J Periodontal Res 46(2):280-284.
23. Aya K, et al. (2005) NF-κB-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis. J Clin Invest 115(7):1848-1854.
24. Yang C, et al. (2010) NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS One 5(11):e15383.
25. Chaisson ML, et al. (2004) Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase α. J Biol Chem 279(52):54841-54848.
26. Maruyama T, et al. (2010) Processing of the NF-κ B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation. J Bone Miner Res 25(5):1058-1067.
27. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289(5484):1504-1508.
28. Lord CA, et al. (2009) Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/Monarch-1. J Immunol 182(5):2948-2958.
29. Arimura T, et al. (2001) Identification, characterization, and functional analysis of heart-specific myosin light chain phosphatase small subunit. J Biol Chem 276(9): 6073-6082.
30. Takeshita S, Kaji K, Kudo A (2000) Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 15(8):1477-1488.
31. Allen IC, et al. (2013) Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and Mycobacterium tuberculosis. PLoS One 8(4): e60842.
32. Bouxsein ML, et al. (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25(7):1468-1486.
33. Dempster DW, et al. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2-17.